Pharma Mar SA (PHMMF)
87.58
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Pharma Mar Market Cap : 1.518B for Aug. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.518B |
| August 20, 2026 | 1.518B |
| August 19, 2026 | 1.518B |
| August 18, 2026 | 1.518B |
| August 17, 2026 | 1.518B |
| August 14, 2026 | 1.518B |
| August 13, 2026 | 1.518B |
| August 12, 2026 | 1.518B |
| August 11, 2026 | 1.518B |
| August 10, 2026 | 1.518B |
| August 07, 2026 | 1.518B |
| August 06, 2026 | 1.518B |
| August 05, 2026 | 1.518B |
| August 04, 2026 | 1.492B |
| August 03, 2026 | 1.492B |
| July 31, 2026 | 1.492B |
| July 30, 2026 | 1.492B |
| July 29, 2026 | 1.492B |
| July 28, 2026 | 1.492B |
| July 27, 2026 | 1.492B |
| July 24, 2026 | 1.494B |
| July 23, 2026 | 1.494B |
| July 22, 2026 | 1.494B |
| July 21, 2026 | 1.494B |
| July 20, 2026 | 1.494B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.494B |
| July 16, 2026 | 1.494B |
| July 15, 2026 | 1.494B |
| July 14, 2026 | 1.494B |
| July 13, 2026 | 1.578B |
| July 10, 2026 | 1.578B |
| July 09, 2026 | 1.638B |
| July 08, 2026 | 1.638B |
| July 07, 2026 | 1.380B |
| July 06, 2026 | 1.380B |
| July 02, 2026 | 1.380B |
| July 01, 2026 | 1.380B |
| June 30, 2026 | 1.380B |
| June 29, 2026 | 1.380B |
| June 26, 2026 | 1.380B |
| June 25, 2026 | 1.380B |
| June 24, 2026 | 1.380B |
| June 23, 2026 | 1.380B |
| June 22, 2026 | 1.380B |
| June 18, 2026 | 1.380B |
| June 17, 2026 | 1.380B |
| June 16, 2026 | 1.380B |
| June 15, 2026 | 1.380B |
| June 12, 2026 | 1.380B |
| June 11, 2026 | 1.848B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oryzon Genomics SA | 260.46M |
| Grifols SA | 2.062B |
| ACADIA Pharmaceuticals, Inc. | 5.100B |
| Alkermes Plc | 8.184B |
| Alnylam Pharmaceuticals, Inc. | 31.57B |
Market Cap Related Metrics
| PE Ratio | 23.41 |
| PS Ratio | 5.978 |
| PEG Ratio | 0.567 |
| Price to Book Value | 5.296 |
| Price to Free Cash Flow | 24.22 |
| Price | 87.58 |
| Earnings Yield | 4.27% |
| PEGY Ratio | 0.5497 |
| Operating PE Ratio | 41.30 |
| Normalized PE Ratio | 23.41 |